Castle Biosciences Inc at Needham Growth Conference (Virtual) Transcript
Great. Thanks for joining us at the 24th Annual Needham Growth Conference. I am Mike Matson, and I lead the med tech and diagnostics equity research team here at Needham & Company. I am pleased to introduce Castle Biosciences' CEO, Derek Maetzold; CFO, Frank Stokes; and Executive Director, Investor Relations and Communications, Camilla Zuckero. Instead of (technical difficulty), we are going to start out with some slides here, a brief presentation, but we are going to spend most of the time doing a Q&A session. (Conference Instructions)
So with that, I will turn things to Derek, and he will go through a few slides before we get into the Q&A. Derek, if you want to go ahead?
Hi, Mike. Thank you for the introduction. Happy new year, everybody. It's good to be here, even if it's over Zoom. I thought I would go through just a couple of slides regarding our year-end results and then, as you said, spend most of the time from a fireside chat
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |